316 related articles for article (PubMed ID: 35426793)
1. [Prognostic implications and functional enrichment analysis of LTB4R in patients with acute myeloid leukemia].
Zhang X; Zhang X; Liu P; Liu K; Li W; Chen Q; Ma W
Nan Fang Yi Ke Da Xue Xue Bao; 2022 Mar; 42(3):309-320. PubMed ID: 35426793
[TBL] [Abstract][Full Text] [Related]
2. Pan-cancer analysis of oncogenic TNFAIP2 identifying its prognostic value and immunological function in acute myeloid leukemia.
Lin MS; Zhong HY; Yim RL; Chen QY; Du HL; He HQ; Lin K; Zhao P; Gao R; Gao F; Zhang MY
BMC Cancer; 2022 Oct; 22(1):1068. PubMed ID: 36243694
[TBL] [Abstract][Full Text] [Related]
3. HIVEP3 cooperates with ferroptosis gene signatures to confer adverse prognosis in acute myeloid leukemia.
Zhang X; Zhang X; Liu K; Li W; Wang J; Liu P; Ma W
Cancer Med; 2022 Dec; 11(24):5050-5065. PubMed ID: 35535739
[TBL] [Abstract][Full Text] [Related]
4. Identification of RHOBTB2 aberration as an independent prognostic indicator in acute myeloid leukemia.
Liu P; Ma Q; Chen H; Zhang L; Zhang X
Aging (Albany NY); 2021 Jun; 13(11):15269-15284. PubMed ID: 34074803
[TBL] [Abstract][Full Text] [Related]
5. Prognostic and immunological value of LTB4R in pan-cancer.
Long S; Ji S; Xiao K; Xue P; Zhu S
Math Biosci Eng; 2021 Oct; 18(6):9336-9356. PubMed ID: 34814348
[TBL] [Abstract][Full Text] [Related]
6. Low expression of the metabolism-related gene SLC25A21 predicts unfavourable prognosis in patients with acute myeloid leukaemia.
Wang W; Liang Q; Zhao J; Pan H; Gao Z; Fang L; Zhou Y; Shi J
Front Genet; 2022; 13():970316. PubMed ID: 36246603
[TBL] [Abstract][Full Text] [Related]
7. m6A genotypes and prognostic signature for assessing the prognosis of patients with acute myeloid leukemia.
Fu C; Kou R; Meng J; Jiang D; Zhong R; Dong M
BMC Med Genomics; 2023 Aug; 16(1):191. PubMed ID: 37596597
[TBL] [Abstract][Full Text] [Related]
8. [Clinical Significance of Low Expression of LncRNA CASC15 in Acute Myeloid Leukemia with NPM1 Mutations].
Xia PH; Xu ZJ; Jin Y; Ma JC; Wen XM; Yuan Q; Leng JY; Qian J; Lin J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Jun; 30(3):659-670. PubMed ID: 35680788
[TBL] [Abstract][Full Text] [Related]
9. Bioinformatics Analysis Identifies Key Genes and Pathways in Acute Myeloid Leukemia Associated with DNMT3A Mutation.
Chen S; Chen Y; Lu J; Yuan D; He L; Tan H; Xu L
Biomed Res Int; 2020; 2020():9321630. PubMed ID: 33299888
[TBL] [Abstract][Full Text] [Related]
10. Identification of the key genes and microRNAs in adult acute myeloid leukemia with FLT3 mutation by bioinformatics analysis.
Chen S; Chen Y; Zhu Z; Tan H; Lu J; Qin P; Xu L
Int J Med Sci; 2020; 17(9):1269-1280. PubMed ID: 32547322
[No Abstract] [Full Text] [Related]
11. Expression analysis, clinical significance and potential function of PLXNB2 in acute myeloid leukaemia.
Guo Z; Guo D; Kong D; Bian S; Zhao L; Li Q; Lin L; Hao J; Sun L; Li Y
Mol Biol Rep; 2023 Oct; 50(10):8445-8457. PubMed ID: 37632633
[TBL] [Abstract][Full Text] [Related]
12.
Bai H; Zhou M; Zeng M; Han L
DNA Cell Biol; 2020 Apr; 39(4):700-708. PubMed ID: 32077754
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance and potential mechanism of heat shock factor 1 in acute myeloid leukemia.
Lyu C; Wang Q; Yin X; Li Z; Wang T; Wang Y; Cui S; Liu K; Wang Z; Gao C; Xu R
Aging (Albany NY); 2022 Sep; 14(17):7026-7037. PubMed ID: 36069792
[TBL] [Abstract][Full Text] [Related]
14. High expression of COMMD7 is an adverse prognostic factor in acute myeloid leukemia.
Li K; Chen L; Zhang H; Wang L; Sha K; Du X; Li D; Zheng Z; Pei R; Lu Y; Tong H
Aging (Albany NY); 2021 Apr; 13(8):11988-12006. PubMed ID: 33891561
[TBL] [Abstract][Full Text] [Related]
15. Identification and validation of inferior prognostic genes associated with immune signatures and chemotherapy outcome in acute myeloid leukemia.
Wang J; Hao JP; Uddin MN; Wu Y; Chen R; Li DF; Xiong DQ; Ding N; Yang JH; Ding XS
Aging (Albany NY); 2021 Jun; 13(12):16445-16470. PubMed ID: 34148032
[TBL] [Abstract][Full Text] [Related]
16. Prognostic biomarker replication factor C subunit 5 and its correlation with immune infiltrates in acute myeloid leukemia.
Li WJ; Wu DW; Zhou YF; Zhang CW; Liao XW
Hematology; 2022 Dec; 27(1):555-564. PubMed ID: 35544695
[TBL] [Abstract][Full Text] [Related]
17. Identification of biomarkers for acute leukemia via machine learning-based stemness index.
Zhang Y; Liu D; Li F; Zhao Z; Liu X; Gao D; Zhang Y; Li H
Gene; 2021 Dec; 804():145903. PubMed ID: 34411647
[TBL] [Abstract][Full Text] [Related]
18. Integrated bioinformatic analysis of mitochondrial metabolism-related genes in acute myeloid leukemia.
Tong X; Zhou F
Front Immunol; 2023; 14():1120670. PubMed ID: 37138869
[TBL] [Abstract][Full Text] [Related]
19. High IL2RA mRNA expression is an independent adverse prognostic biomarker in core binding factor and intermediate-risk acute myeloid leukemia.
Du W; He J; Zhou W; Shu S; Li J; Liu W; Deng Y; Lu C; Lin S; Ma Y; He Y; Zheng J; Zhu J; Bai L; Li X; Yao J; Hu D; Gu S; Li H; Guo A; Huang S; Feng X; Hu D
J Transl Med; 2019 Jun; 17(1):191. PubMed ID: 31171000
[TBL] [Abstract][Full Text] [Related]
20. Identification and validation of a siglec-based and aging-related 9-gene signature for predicting prognosis in acute myeloid leukemia patients.
Shi H; Gao L; Zhang W; Jiang M
BMC Bioinformatics; 2022 Jul; 23(1):284. PubMed ID: 35854240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
